115 related articles for article (PubMed ID: 24504679)
1. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
Wang P; Sun L; Yu L; Wang H
Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
[No Abstract] [Full Text] [Related]
2. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
[TBL] [Abstract][Full Text] [Related]
3. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
Guo HB; Xiao T
Tumour Biol; 2014 May; 35(5):5053. PubMed ID: 24449508
[No Abstract] [Full Text] [Related]
4. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
5. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
He S; Xiao Z; Chen L; Xiong S
Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
[No Abstract] [Full Text] [Related]
6. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
Liu F; Zhang Q
Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
[TBL] [Abstract][Full Text] [Related]
7. Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".
Li Z; Li Y
Tumour Biol; 2014 May; 35(5):5051. PubMed ID: 24390666
[No Abstract] [Full Text] [Related]
8. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
[TBL] [Abstract][Full Text] [Related]
11. NPRL2 is an independent prognostic factor of osteosarcoma.
Gao Y; Wang J; Fan G
Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in patients with osteosarcoma].
Ying M; Zhang W; Liu Z
Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):93-6. PubMed ID: 7656713
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
Ren W; Gu G
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
[TBL] [Abstract][Full Text] [Related]
15. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
[TBL] [Abstract][Full Text] [Related]
16. Letter regarding Wang et al. entitled "Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systematic review and meta-analysis".
Bilbao-Aldaiturriaga N; Martin-Guerrero I; Garcia-Orad A
Tumour Biol; 2014 Jul; 35(7):6179. PubMed ID: 24682904
[No Abstract] [Full Text] [Related]
17. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
Jian Y; Tian X; Li B; Zhou Z; Wu X
Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
[TBL] [Abstract][Full Text] [Related]
18. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
19. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
Zhang Q; Li J; Liu F; Li Z
Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
[TBL] [Abstract][Full Text] [Related]
20. Letter regarding Chen et al. entitled "a systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma".
Liu LH; Li H; Xiao T
Tumour Biol; 2014 Sep; 35(9):8535. PubMed ID: 25168371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
